Insulet | Üzemi Eredmény



Operating Profit változás Dátum
Abbott USD 1.91B 41M 2024-12
Align Technology USD 144.15M 18.15M 2024-12
AtriCure USD -14523000 7.12M 2024-12
Avanos Medical USD -418500000 430.5M 2024-12
Baxter International USD -435000000 590M 2024-12
Becton, Dickinson and Co. USD 453M 195M 2024-12
Boston Scientific USD 675M 58M 2024-12
Cardinal Health USD 549M 19M 2024-12
Cooper Companies USD 182M 16.4M 2025-01
Dexcom USD 188.9M 36.9M 2024-12
Edwards Lifesciences USD 312.6M 38M 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Globus Medical USD 60.27M 12.18M 2024-12
ICU Medical USD 37.69M 29.46M 2024-12
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 35.23M 43.36M 2024-12
J&J USD 3.89B 549M 2024-12
Masimo USD -359100000 389.2M 2024-12
Medtronic USD 1.65B 51M 2025-01
Merit Medical Systems USD 36.56M 697K 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12
Solventum Corp 136M 139M 2024-12
Stryker USD 581M 504M 2024-12
Tandem Diabetes Care USD -582000 25.51M 2024-12
Teleflex USD -110383000 259.69M 2024-12
West Pharmaceutical Services USD 159.6M 1.7M 2024-12
Zimmer Biomet Holdings USD 389M 109.5M 2024-12



Insulet Üzemi Eredmény - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2025.